news FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner. by twn7r September 30, 2022 4 The Food and Drug Administration on Thursday approved the use of Relyvrio to treat amyotrophic lateral sclerosis, more commonly known as ALS.
